UK markets closed

Sinopharm Group Co. Ltd. (X2S.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.5520+0.0790 (+3.19%)
As of 08:00AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
591,685,676
552,147,550
521,051,235
456,414,611
Cost of revenue
-
504,713,490
477,000,627
416,091,300
Gross profit
-
47,434,060
44,050,608
40,323,311
Operating expenses
Selling general and administrative
25,938,486
24,903,120
23,198,526
21,191,553
Total operating expenses
63,770,263
24,226,957
22,609,333
20,539,551
Operating income or loss
17,758,347
23,207,103
21,441,275
19,783,760
Interest expense
3,444,856
3,520,326
3,756,835
3,424,756
Income before tax
19,000,579
18,563,819
17,003,162
15,598,096
Income tax expense
4,400,314
4,218,377
3,938,389
3,500,805
Income from continuing operations
14,600,265
14,345,442
13,064,773
12,097,291
Net income
8,765,042
8,525,655
7,758,646
7,187,278
Net income available to common shareholders
8,765,042
8,525,655
7,758,646
7,187,204
Basic EPS
2.81
2.73
2.49
2.31
Diluted EPS
2.81
2.73
2.49
2.31
Basic average shares
3,116,890
3,120,656
3,111,169
3,111,169
Diluted average shares
3,116,890
3,120,656
3,111,169
3,111,293